Results 291 to 300 of about 117,210 (347)

The distribution and the clinical importance of MUC5B and TERT variants in Turkish patients with idiopathic pulmonary fibrosis. [PDF]

open access: yesBMC Pulm Med
Ödemiş A   +7 more
europepmc   +1 more source

Quality of life in patients with hypersensitivity pneumonitis and with idiopathic pulmonary fibrosis in real-life clinical practice. [PDF]

open access: yesJ Thorac Dis
Suvorova OA   +7 more
europepmc   +1 more source

Genome-wide analysis of tandem repeat variation identifies SLC15A4 as a susceptibility gene for idiopathic pulmonary fibrosis

open access: yes
Oketch JW   +15 more
europepmc   +1 more source

Masthead: (View 6/2025)

open access: yes
VIEW, Volume 6, Issue 6, December 2025.
wiley   +1 more source

Polygenic Risk and Rare Variants in Endotypes of Idiopathic Pulmonary Fibrosis

open access: yes
Duckworth A   +18 more
europepmc   +1 more source

Idiopathic Pulmonary Fibrosis

Seminars in Respiratory and Critical Care Medicine, 2012
Idiopathic pulmonary fibrosis (IPF) is a specific form of progressive, chronic fibrosing interstitial lung disease occurring primarily in older adults and limited to the lungs. The prognosis is dire, with half of all patients progressing to death from respiratory failure within 3 to 5 years from initial diagnosis. The pathogenesis of IPF is complex and
Jessica M, Adkins, Harold R, Collard
openaire   +4 more sources

Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

Immunology and Allergy Clinics of North America, 2023
Idiopathic pulmonary fibrosis (IPF), a common interstitial lung disease (ILD), is a chronic, progressive fibrosing interstitial pneumonia, with an unknown cause. IPF has been linked to several genetic and environmental risk factors. Disease progression is common and associated with worse outcomes.
Rachel, Strykowski, Ayodeji, Adegunsoye
openaire   +2 more sources

Home - About - Disclaimer - Privacy